Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Methotrexate in ERosive INflammatory Osteoarthritis (MERINO) Trial: A Randomized Placebo-controlled Trial to Investigate Clinical Efficacy and Safety of Methotrexate in Erosive Inflammatory Hand Osteoarthritis.

NCT04579848 is registered in ClinicalTrials.gov with Diakonhjemmet Hospital as lead sponsor.

NCT NCT04579848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04579848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Methotrexate in ERosive INflammatory Osteoarthritis (MERINO) Trial: A Randomized Placebo-controlled Trial to Investigate Clinical Efficacy and Safety of Methotrexate in Erosive Inflammatory Hand Osteoarthritis.
Lead sponsor
Diakonhjemmet Hospital
Phase
Phase 4
Overall status
Active, not recruiting
Start date
August 12, 2021
Completion date
December 31, 2026
Enrollment
163 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erosive osteoarthritis, hand osteoarthritis